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SUMMARY 
Iron is an important element. It is mainly absorbed by 
the intestinal mucosal cells. After binding with plasma 
transferrin, it is transported to various tissues 
according to their functional needs. Since there is no 
effective means to excrete iron, the balance of total 
body iron is maintained by regulation of absorption• 
Increase in iron absorption may lead to iron 
accumulation, especially in the liver, heart and 
pancreas. This may result in tissue damage and in turn 
lead to organ failure. 
This project is to study the distribution of hepatic iron 
in a Hong Kong Chinese population, for it has not been 
done previously and results may provide information for 
the investigation of the apparently low incidence of 
genetic hemochiromatosis in this community. 
Iron deposition in the liver was assessed by employing 
histological techniques. Data obtained were correlated 
with various parameters including sex, age, pattern of 
systemic iron distribution and iron concentration 
determined chemically. It was found that there is a 
relatively high incidence of siqnificant hepatocvtic 
siderosis in the studied group. It occurs predominantly 
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in the late adulthood and in males. Iron is distributed 
both in hepatocytes and Kupffer cells in the liver which 
suggests a combination of increased iron absorption 
secondary to ineffective erythropoiesis and parenteral 
overload. It is not the pattern of genetic 
hemochromatosis in most patients. A significant number of 
patients with excessive iron deposition also reveals 
siderosis in systemic tissues with some clinical evidence 
of resultant disease (i.e. diabetes mellitus). 
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INTRODUCTION 
Iron is involved in a number of metabolic processes, and 
one of its most important functions is for the synthesis 
of hemoglobin• In normal individuals, iron is kept in 
equilibrium by means of excretion and regulated 
absorption. Once iron is absorbed, it will bind to a 
serum protein, transferrin, and is transported mainly to 
the bone marrow where it is utilized for hemoglobin 
synthesis. When iron is not in use, it is stored in the 
form of ferritin and hemosiderin. Several mechanisms may 
contribute to the iron accumulation where excessive iron 
stored eventually leads to tissue damage and organ 
failure. 
Iron overload is associated with many disorders. 
Idiopathic hemochromatosis is a hereditary disorder of 
iron metabolism with an increased intestinal iron 
absorption from a diet with normal iron content. 
Secondary hemochromatosis may result from increased 
absorption of iron due to ingestion of large amount of 
dietary iron; ineffective erythropoiesis; or compensation 
for hemolytic anemias as in thalassemia/ iron overload 
can also be acquired parenterally in the form of 
transfusional hemosiderosis, where most of the iron is 
stored in the reticuloendothelial system. 
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These various forms of iron storage disease may result 
in fibrosis and heavy iron deposition where they are 
found predominantly in the parenchymal cells of the 
liver, as well as in other organs such as heart, 
pancreas, and pituitary. Iron toxicity thus induces 
tissue damage, resulting in organ dysfunction (1, 2)• 
Since beta—thalassemias are common (3) and the incidence 
of hepatitis B associated hepatic carcinoma is high in 
Hong Kong ( 4, 5, 6 ) , a high prevalence of hepatic 
siderosis is possible. Therefore, it will be of interest 
to investigate the magnitude of iron storage in this 
population. 
Aims 
This study hopes to extend this body of knowledge by 
fulfilling the following aims: 
1- To establish the validity of histological grading 
system for estimation of iron content and compare it with 
chemical deteriniiiation of iron content. 
2. To establish the range of hepatic iron stores in 
normal individuals. 
3. To determine the incidence of genetic 
hemochromatosis in the Hong Kong population. 
4. To perform a comprehensive survey of a population 
which is hospital based from which a control group is 
extracted. Results will be used to establish a baseline 
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of normality pertaining to hepatic iron stores in 
individuals in this community and correlate statistically 
with factors such as age, sex, degree of fibrosis to the 
extent of siderosis. 
5. Information obtained will be used to determine if 
results pertaining to the hospital group are applicable 
to the general population. 
6. This survey can provide evidence for genetic 
hemochromatosis in a Hong Kong Chinese population, where 
the incidence of this disorder is thought widely by local 
experts to be low in this community (unpublished 
observations. ) „ 
7. 工 iron storage will be studied using histological 
grading system and chemical estimation in the liver, 
since these are the methods used in assessing tissue iron 
i.e. they are direct indications of the amount of iron 
in the target tissue• 
Both methods are used because: 
(i) there is some debate as to whether or not the 
histological grading system is always a true reflection 
of the tissue iron. 
(ii) histological grading is appropriate for use 
by Anatomical Pathologists and is relatively simple and 
can be semi-quantitative. 
(iii) chemical estimation is probably the "gold 
standard", however, it is not routinely done for it is 
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more complex and results in destruction of the tissue. 
The histological method , therefore , may not be 
the "gold standard" but it does represent the major 
practical method for assessing tissue iron. In this 
study, due to the availability of post mortem material, 
we are able to employ both methods, thus , allowing us to 
correlate the findings of each. 
8. With this protocol, it may be possible to determine 
the incidence of potential iron storage disease and draw 





Iron is a vital element for growth, and is an essential 
constituent for hemoglobin synthesis, myoglobin 
synthesis, and the synthesis of iron—containing enzymes. 
The total iron content in normal adult man is 
approximately 50 mg/kg body weight (7), of which two 
thirds or more is found in heme compounds, such as 
hemoglobin and myoglobin. Around one-third is in storage 
iron (ferritin and hemosiderin) and labile iron pool, and 
the rest in iron—containing enzymes. 
1.1 Excretion 
Excretion is discussed first for reason of coherency. In 
normal individuals, the total body iron should be in a 
relatively steady state. Therefore, the loss of iron 
must be balanced by the absorption of iron from food. 
However, little iron is lost from the body. In man, it 
takes place only when mucosal cells from the 
gastrointestinal tract, epidermal derivatives from skin 
and desquamated cells from urine are shed. The average 
daily loss of iron has been estimated at about 1.0 mg/day 
in normal adult and non-menstruating woman (8) . iron 
loss in menstruating woman and pregnant female is higher, 
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and amounts to 2 to 3 . 5 times that of normal 
individual. 
1.2 Absorption 
In general, these losses are balanced by control of 
absorption and iron from a normal diet can usually meet 
this requirement. However, nutritional patterns vary a 
great deal in different parts of the world. The amount 
of iron ingested is very much dependent on the type of 
food eaten, as well as the type of utensils used for 
cooking. It is known that iron cookware can contribute a 
considerable amount of iron to the food cooked in-it. As 
is exemplified in the case of Bantu siderosis (9), an 
abnormally high dietary iron intake due to the use of 
iron utensils for cooking and brewing wines predisposes 
these individuals to hepatic iron overload. 
Iron is largely absorbed in the small intestine, and the 
efficiency of absorption is governed by the presence of 
varying amount of specific receptors in the brush borders 
at different sites. In man, iron is absorbed in two 
forms - as heme and non-heme compounds. A number of 
factors can influence non-heme absorption, but have no 
effect on heme iron. Natural chelators such as 
succinate, fructose (10), ascorbic acid (11) may form a 
complex with iron, facilitating iron absorption. On the 
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other hand, phosphate, phytate, pancreatic secretions and 
alkali (12) can depress iron absorption. Most of the non-
heme iron is reduced to the ferrous state in the stomach 
where the gastric juice acts as medium for reduction of 
iron. Ferrous iron is then taken up by the mucosal cells 
within the intestine by specific receptors (13) which 
then binds to an intracellular protein (14) , and is 
subsequently transported out of the cell into 
circulation. Impaired absorption is observed in patients 
with gastrectomy and achlorhydria• However, gastric 
hydrochloric acid by itself is of minor importance, as 
even after addition of dilute hydrochloric acid to the 
food, it does not appear to improve iron absorption in 
these patients. 
Heme iron is mainly derived from hemoglobin, and other 
heme proteins. When in contact with the gastric juice, 
heme will be set free from its apoprotein. When the heme 
molecules enter the mucosal cells, iron is extracted from 
the porphyrin ring by an enzymes, heme oxygenase (15), 
and iron is released. 
Three important factors are responsible for the 
regulation of iron absorption. The first being the 
amount of body stored iron. In general, when iron stores 
are depleted, iron absorption increases, and vice versa. 
The second and the third factors are the rate of 
erythropoiesis and the amount of iron ingested. Increase 
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in erythropoietic activity results in enhanced iron 
absorption whereas a decrease in red cell production 
leads to reduced iron absorption. Iron absorption can 
also be elevated when an excessive amount of iron is 
taken orally. 
It has been broadly accepted that iron is taken up by the 
mucosal epithelial cell in the gut lumen, retained 
in the mucosal storage pool and finally transported out 
to the plasma. A recent study by McLaren (16) has shown 
that serum ferritin concentration is inversely 
proportional to the rate constants for mucosal iron 
uptake and mucosal iron transfer. However it has no 
effect on the retention rate. This suggests that control 
of absorption of iron is mediated by regulation of 
mucosal iron uptake which in turn is influenced by 
total body iron stores. 
A study by Peters (17) also indicates that chronic 
hypoxia may enhance intestinal iron absorption, where it 
can result in an increase in mucosal iron uptake. 
One proposal (18) suggested that iron absorption is 
regulated by the movement of iron between plasma and 
tissue. According to the researcher, the probability of 
an iron atom being picked up by a transferrin molecule is 
proportional to the product of the exchangeable iron in 
that tissue and plasma iron turnover but inversely 
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proportional to the exchangeable iron in the whole body, 
therefore, iron absorption could be expressed as 
tissue exchangeable iron 
— X plasma iron turnover 
total exchangeable iron 
Since total iron available for binding by transferrin is 
related to iron stores, the rate of absorption is 
influenced by iron deficiency or overload. 
1-3 Iron Transport and Storage 
1.3.1 Transferrin 
After leaving the cells, iron enters the circulation and 
combines with a plasma protein called transferrin• 
Transferrin bound iron is transported from intestinal 
mucosal cells via plasma to different tissues. Plasma 
transferrin is a beta globulin of molecular weight about 
80,000 and is mainly synthesized by liver hepatocytes. 
It has a single polypeptide chain and two iron—binding 
sites, with a preferential binding of iron at the N-
terminal end (19). Variant forms of transferrin are 
demonstrated by gel electrophoresis (20) but they show 
common biological and physiological properties• 
Several studies have brought forward evidence that 
transferrin receptors are present on many types of cells, 
including the liver (21,22,23,24), placenta (25,26), and 
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erythroid cells (27). It is thought that transferrin— 
bound iron is taken up by the cells through interaction 
between transferrin and specific cell membrane receptors. 
For erythroid cells, it has been suggested that after 
binding with specific membrane receptors, iron and 
transferrin enter the cell together by endocytosis (28) 
through the coated pits. Then iron is released and 
finally the iron—depleted transferrin molecule will 
return to plasma for circulation. 
Some reports have demonstrated that changes in pH, ionic 
strength of the medium and the presence of promoting 
agents such as isoniazid, succinylacetone and inhibitors 
such as hemin, cycloheximide can change the rates of 
transferrin endocytosis and iron uptake in erythroid 
cells (29,30). In addition, through studies of different 
vertebrates, it is found that the rate of endocytosis is 
highly associated with the rate of iron uptake 
(31,32,33). All of these information indicate that 
transferrin endocytosis is an important requirement for 
the uptake of iron. Moreover, there has been the 
suggestion that the acidity in the endosome may have 
reduced the iron to a ferrous state which may in turn 
enhance the release of iron from transferrin (34,35,36). 
A study shows that non-transferrin-bound iron can also be 
taken up by reticulocytes (37) • 
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A few studies have demonstrated that the major route for 
the uptake of transferrin一bound iron by hepatocytes is 
through transferrin endocytosis (38,39), mediated by 
specific membrane receptors (23)• However, as plasma 
transferrin iron increases, non-specific adsorption and 
fluid phase endocytosis become important 
(21,23,40,41,42)• 
Soda et al.(43) proposed that sinusoidal endothelium may 
prevent transferrin from moving freely. However, there 
is no substantial evidence to support this concept. In 
contrast, there are more observations supporting the 
theory of a bidirectional movement of the transferrin 
across the sinusoidal endothelia (22,44,45). 
A recent study by Tavassoli (46) has indicated that liver 
endothelium can take up transferrin-bound-iron where 
transferrin is desialated. This process can enhance the 
uptake of iron by hepatic asialoglycoprotein receptors. 
Furthermore, hepatocytes are shown to be able to take up 
non-transferrin-bound iron (47,48,49), and iron bound to 
chelators such as citrate, desferrioxaitiine and tricine. 
A series of studies conducted by Kaplan et al. (50) 
revealed that massive iron deposition was present in the 
parenchymal cells of the liver, pancreas and heart, 
after intravenous injection of radiolabelled iron into 
13 
the hypotransferrinemic mouse. They have demonstrated 
that iron uptake is responsible by a transferrin— 
independent system in the tissue parenchyma in the 
absence of apotransferrin. The studies suggest that 
(i) transferrin is not essential for intestinal mucosal 
absorption of iron/ (2) transferrin is not required for 
the recycling of iron by macrophages； (3) a transferrin-
independent system is present for hepatocytic iron 
accumulation and (4) that in mice with the transferrin 
fully saturated, oral ingestion of radiolabelled iron 
distributes predominantly to the liver initially, then 
apparently redistributes in the following order: to the 
pancreas, the spleen and to a lesser extent the 
bone marrow. 
1.3.2 Storage 
Most of the storage iron is stored as ferritin and 
hemosiderin. 
a) Ferritin — Ferritin is the soluble form of storage 
iron found in tissues and plasma. It is generally 
believed that iron can stimulate the synthesis of 
ferritin, and ferritin arises predominantly from the 
mononuclear phagocytic system and the hepatocytes. The 
ferritin molecule has a molecular weight of about 460,000 
dalton and is made up of clusters of ferric 
hydroxyphosphate bound to an apoprotein shell with a 
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central hollow core, capable of containing up to 4,000 
atoms of iron. Twenty four subunits of two distinct 
types designated H and L of the apoprotein shell have 
been identified (51). Different ferritin molecules 
called isoferritin which differ both in isoelectric point 
and amino acid sequence have also been isolated from 
human tissues (52) . The role of ferritin in iron 
transport remains to be elucidated. 
Hemosiderin - It is the term used to describe the blue 
granules in liver and bone marrow sections after being 
stained with potassium ferrocyanide• Hemosiderin granules 
are heterogenous (53) and are water soluble. It appears 
that hemosiderin is an amorphous condensation of iron 
particles derived from the protein degradation of 
ferritin (54) and it is the residue of ferritin protein 
after lysosomal digestion (55) • 
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CHAPTER 2 
DISEASES ASSOCIATED WITH IRON 
DEFICIENCY OR OVERLOAD 
2.1 Iron Deficiency Anemia 
Normal biosynthesis of hemoglobin requires adequate 
amount of iron, protoporphyrin and globin. When iron is 
deficient, it hinders normal hemoglobin synthesis and 
results in anemias. Iron may be unavailable because it 
is in short supply, or a defect is present in the 
metabolic pathway that makes iron unavailable for the 
erythroid precursors. 
Factors leading to iron—deficiency anemias are summarized 
in Table 2.1 
Table 2.1 Factors leading to iron-deficiency anemias 
1. Decreased nutritional iron intake 






3• Increased iron requirement 
(i) infancy 
(ii) pregnancy and lactation 
(iii) prematurity 
4• Increased iron loss 
(i) chronic hemorrhage e.g.gastrointestinal bleeding 
(ii) parasitic infestation e.g. hookworm 
2.1.1 Nutritional deficiency 
Insufficient iron intake leading to iron deficiency is 
probably the most common cause of anemia. It is uncommon 
in developed countries, but may account for a negative 
iron balance in underdeveloped areas. Iron deficiency is 
often found in infants and children who are fed with milk 
that contains no iron supplement (56) and in individuals 
who have special diet due to religious reasons. 
2.1.2 Impaired absorption 
Diminished absorption is often seen following 
gastrectomy. Factors contributing to this effect are the 
reduction of gastric acidity and the loss of other 
gastric secretions essential to iron absorption (57). A 
high percentage of subjects who are deficient in iron 
exhibits histamine-fast achlorhydria (58). 
Poor absorption can accompany infection (59) and 
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inflammation, however, absorption will return to normal 
when inflammation subsides (60)• 
Pica, which is a habitual ingestion of unusual substances 
such as earth, clay and ice is a possible cause for iron 
deficiency. Crosby (61) found that about 50% of his 
iron—deficient patients had this peculiar habit-
2-1.3 Increased iron requirement 
There are conditions in which extra iron is required, 
such as infancy, prematurity, pregnancy and lactation. 
Infancy — Iron stores at birth are relatively limited, 
only abut 30 mg (62) . As the infant grows, especially 
during the first year of life where the relative growth 
rate is most rapid, additional iron is needed for the 
growing tissues, and the almost doubled hemoglobin mass 
(63) • Since milk is a poor source of iron, if no other 
supplement is introduced, it can lead to the development 
of iron deficiency in the infant. 
Another important factor that influences the iron stores 
in the newborn is the early clamping of the umbilical 
cord at birth. A considerable amount of blood may be 
trapped in the placenta, resulting in a decrease in red 
cell volume of the infant. 
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Prematurity - Infants born prematurely tend to develop 
anemia. These newborns require more iron than full-term 
infants, as their stored iron is less, and growth rate is 
faster. 
Pregnancy and lactation - Pregnancy is one of the 
physiological conditions where increased iron is 
required. Over a full term pregnancy, the iron 
requirement amounts to 2.5 mg/day and increases to 3 -
7.5 mg/day in the third trimester. Even with the best 
diet, this increase in demand cannot be met easily, hence 
iron deficiency often occurs (64)• 
2.1.4 Increased iron loss 
Chronic hemorrhage 一 Chronic blood loss is a common cause 
of anemia. Gastrointestinal bleeding which includes 
duodenal and gastric ulcers (65), diverticulosis (66), 
esophageal hiatal hernia (67) and carcinoma, accounts 
for a great proportion in this category. Blood loss can 
be massive or mild and may even go unnoticed for a 
prolonged period of time until the symptoms of anemia 
surface. 
Parasitic infestation - Infestation by hookworm can 
result in anemia. The worms attach themselves to the 
upper small intestine and feed on the host's blood. This 
loss can be considerable, depending on the number of 
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worms harboured, and often is complicated by pregnancy, 
and deficient diet. 
2.2 Iron Overload 
As we recall the ineffective excretory mechanism of iron 
in human, we can easily visualize that in any anemia that 
is not due to blood loss, the iron derived from 
hemoglobin breakdown can be redistributed to stores where 
it produces the histological picture of hemosiderosis. 
This is especially true for hemolysis. In addition, iron 
overload may be produced in association with increased 
dietary iron and parenteral administration of iron. The 
causes for iron overload are summarized in Table 2.2. 
Table 2.2 Causes for iron overload 
1. Increase in absorption 
(A) from normal intake of dietary iron 
(i) hereditary hemochromatosis 
(ii) iron loading anemias with ineffective 
erythropoiesis -
e.g. thalassaemia, sideroblastic anemia. 
(iii) chronic liver disorder e.g. alcoholic cirrhosis 
(iv) congenital defect e.g. atransferrinemia 
(B) from increased dietary iron 
—African dietary overload 
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2. Parenteral iron overload 一 multiple transfusion 
一 chronic hemolysis 
3. Focal iron deposition 
(i) idiopathic pulmonary hemosiderosis 
(ii) porphyria Cutanea Tarda 
4. Neonatal hemochromatosis 
2.2.1 Increased Iron Absorption 
Iron overload may be produced by an increased absorption 
of dietary iron. This may be due to i) a derangement in 
the intestinal mucosa, where an abnormally high amount of 
iron is absorbed; or ii) ingestion of large amount of 
iron in the diet. 
A. Increased absorption from normal dietary intake : 
(i) Hereditary hemochromatosis - it is an inherited 
disorder and is transmitted by an autosomal recessive 
trait. Simon et al • (68) reported an association 
between the HLA alloantigen A3 and hemochromatosis. The 
HLA complex is located on the short arm of chromosome 6. 
More recent work from Dadone et al. (69) and Lalouel et 
al. (70) showed that there is a close relationship 
between the major histocompatibility complex and 
idiopathic hemochromatosis locus. 
21 
In homozygotes for hereditary hemochromatosis, there is a 
mucosal defect in the small intestine, which makes them 
unable to refrain from absorbing unneeded iron, thus a 
chronic positive iron balance results. Excess iron is 
deposited predominantly in the parenchymal cells, and 
only during the late stage of the disease, after organ 
injury and cirrhosis have developed, that iron stores in 
reticuloendothelial cells increases (71)• 
In heterozygotes, the disorder is only mild. These 
individuals usually do not develop clinical symptoms, 
however, abnormal biochemical findings are observed (72) 
and relatively low grade hepatocytic siderosis -with a 
typical periportal distribution is noted. 
(ii) Iron loading anemias - It has been pointed out 
earlier that increased erythropoiesis can influence iron 
absorption. Increased iron storage is frequently 
associated with chronic refractory anemias, such as beta— 
thalassaemia, sideroblastic anemia, pyruvate kinase 
deficiency and other hemoglobinopathies (73) , which are 
common in this region (74) • 
Thalassemias are characterized by the presence of mutant 
genes which suppress the synthesis of one or more of the 
polypeptide chains of normal hemoglobin (75)• Due to the 
imbalance in the globin molecule, chains which are normal 
tend to form aggregates, which in turn damage cell 
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membrane and lead to early cell destruction. In this 
instance, iron absorption increases to meet the demand 
for rapid replacement of erythrocytes, however, at the 
same time, excess iron is also released from hemoglobin 
breakdown. Hence, this cause and effect relationship 
contributes to excess storage iron. 
Sideroblastic anemia - It is marked by the presence of 
excess mitochondrial iron deposits within the 
normoblasts. Ultrastructural examination reveals that 
these deposits consist of ferric oxide (76) or ferric 
phosphate (77). The term 'ringed sideroblast, refers to 
the peculiar distribution of positive granules formed as 
a full or partial ring after cells are being stained with 
Prussian Blue. Aoki (78) suggested that there is a 
mitochondrial defect leading to the impairment of heme 
synthesis. Heme acts as a feedback inhibitor in 
controlling the uptake of iron by the maturing red cell, 
and any deficiency in it, may result in the accumulation 
of iron. 
Drugs and toxins are also found in association with 
sideroblastic anemia. Isoniazid used in the therapy of 
tuberculosis (79), chloramphenicol and chemotherapeutic 
agents such as azathioprine are drugs known to have an 
inhibitory effect on the enzymatic pathway in heme 
synthesis. 
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(iii) Chronic liver disorder - A number of chronic 
hepatic disorders may be associated with iron overload. 
Studies have shown that, although alcohol can stimulate 
collagen synthesis (80), the modest elevation in hepatic 
iron stores in alcoholic cirrhosis may not be alcohol 
dependent. The hepatotoxic effect of alcohol could be 
synergistic in patients who are genetically susceptible 
(81)• Alcohol ingestion, by itself, has no influence on 
heterozygotes of hemochromatosis (82), but it may 
facilitate the expression of the H gene, and enhance 
absorption in homozygotes (83) . Furthermore, portacaval 
shunting has been demonstrated to enhance hepatic 
siderosis (84). A recent report by Capron et al. (85) 
also suggested that spontaneous portosystemic shunting 
may lead to hepatic iron deposition. 
(iv) Congenital defect - Atransferrinemia, a congenital 
disease, has been reported to be a cause for iron 
overload (86)• The absence of transferrin results in 
impaired iron transport, allowing no iron to enter the 
bone marrow, but instead, diverts it to deposit freely in 
the liver, spleen, pancreas and heart. 
B. Increased absorption from excessive dietary ijron : 
African iron overload - Iron overload has been 
demonstrated in Bantu (87,88) and sub-Saharan Africans 
(89) • It has been shown that hepatic parenchymal iron 
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deposition in these individuals is due to excess dietary 
iron derived from cooking utensils and home-brewed 
beverages. The ferrous iron in the beverages is absorbed 
by the gastrointestinal tract, subsequently depositing 
both in the Kupffer cells and hepatocytes of the liver. 
Increase in hepatic iron is also seen in Kaschin-Beck 
disease. Early researchers suggested that the high iron 
content in the drinking water was responsible for the 
abnormal skeletal development in these patients (90), 
however, others believed that the decreased calcium 
content with an increase in other metals such as iron, 
lead and zinc in the bones had attributed to the bones 
and joints deformity (91). The pathogenesis of this 
disease remains to be elucidated, 
2.2.2 Parenteral iron overload : 
Transfusional overload - Blood t;ransfusion as a cause of 
iron accumulation has long been observed in patients with 
refractory anemias. This is especially true in patients 
with thalassaemia major due to its chronic dependency on 
red blood cells transfusion. In these patients, iron 
from senescent transfused cells is deposited in the 
reticuloendothelial system initially, and as iron 
accumulates, it rapidly redistributes to parenchymal 
tissues (92,93). Very often hemosiderosis can be 
observed in the hepatocytes even before transfusion 
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therapy has begun. This is due to increased absorption 
by the stimulating effect of the anemic state in these 
individuals (94). 
Transfusional iron overload may also develop in patients 
with sickle cell disease after receiving multiple 
transfusions (95). 
2.2,3 Focal iron deiposition 
(i) Porphyria cutanea tarda 一 工 t is a chronic acquired 
disorder of porphyrin metabolism related to reduced 
activity of uroporphyrinogen decarboxylase (96). - It is 
characterized by excessive hepatic production of 
uroporphyrin I. This disorder is usually associated with 
an increase in liver iron storage, blistering, and 
hyperpigmentation of the skin induced by sunlight. There 
are two forms of porphyria cutanea tarda, namely sporadic 
and familial • A recent study by Beaumont et al • (97) 
has demonstrated that a hemochromatosis allele is not 
responsible for the expression of porphyria cutanea 
tarda. However, another recent study by Edwards et al. 
(98) indicates a contradictory result. 
B. Idiopathic pulmonary hemosiderosis — In this 
syndrome, accumulation of iron is seen in pulmonary 
macrophages in the lung due to multifocal hemorrhage from 
alveolar capillaries (99)• 
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2.2.4 Neonatal hemochromatosis 
This topic deserves special attention since there are 
several reports covering this entity (100,101,102). 
Conventionally, idiopathic hemochromatosis is a disease 
of mid or late adulthood, however, recently a similar 
entity is being reported in young children and neonates. 
Infants diagnosed with this syndrome are often born 
prematurely and characteristically exhibit an increase in 
parenchymal iron in the liver. Development of excess 
iron deposition in pancreas, thyroid, and heart are also 
being reported (103) • Blisard et al. (102) has ruled out 
the possibility of extramedullary hematopoiesis as a 
cause of iron overload, although active hemoglobin 
synthesis is associated with infancy. 
A report by Jacknow et al. (104) suggested that this 
disease was inherited as an autosomal dominant trait and 
a mutant ferritin was present which facilitated iron 
uptake. Interestingly the mother and one sibling of an 
affected family were found to have an increase in serum 
transferrin but undetectable ferritin. 
Since infants in all reported cases were presented with 
an increase in iron deposition at birth, iron 
accumulation must have been occurred in utero. The fetus 
acquires its iron from the maternal transferrin, which is 
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transported through the trophoblastic brush border of the 
placenta (105,106,107). An increase in the number of 
placental transferrin receptors regulates the amount of 
iron transport in favor of the fetus in order to satisfy 
its requirements (108)• 
Due to insufficient clinical data, the pathogenesis of 
this lethal disease is unknown. Whether it is due to a 
dysfunction in the liver, an abnormal absorption 
resembling that of an adult idiopathic hemochromatosis, 
the inheritance of mutant ferritin which facilitates 
hepatic iron uptake or may be a non-specific reaction to 
liver injury remains to be answered (109)• „ 
2.2.5 Iron status in Hong Kong population 
The incidence of beta—thalassemia (3,74), hepatitis B, 
and its associated hepatocellular carcinomia is high in 
Hong Kong (6). Several studies have shown that serum 
ferritin level are elevated in these thalassemic 
individuals (110,111), as well as in healthy elderly 
subjects (Woo et al., 1988, unpublished paper) in this 
community. All these may be due to increased body iron 
stores. 
2.2.6 Prevalence of iron overload in other populations 
Recent observations on the prevalence of iron overload by 
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employing various methods such as serum ferritin, 
transferrin saturation and HLA typing indicate that 
idiopathic hemochromatosis is more common than has been 
thought. Results from all studied geographical areas have 
shown that idiopathic hemochromatosis is strongly 
associated with HLA-A3. Gene frequency has been estimated 
between 6-7%. 
Studies from Canada, Sweden, United Kingdom, Australia 
and Africa revealed a prevalence of 0.27, 0.5, 0�3, 0.3, 
and 0.82 respectively, with the highest estimate being an 
African population (112, 113, 114, 115, 116). 
2.3 Iron Storage Disease 
Hemochromatosis may be defined as a general descriptive 
term for patients who have iron storage overload 
producing a disease. 
Hemosiderosis is iron overload but it does not imply a 
disease due to the overload. 
These are the definitions used in this thesis. The 
various disorders can be classified as: 
1- Primary (genetic) hemochromatosis —工t is a hereditary 
disorder of iron metabolism resulting in iron overload in 
the parenchymal cells of the liver and other organs, 
where fibrosis or organ dysfunction ultimately occurs. 
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There is a mucosal defect in the small intestine which 
allows an inappropriately high absorption of iron. 
Patients in this category usually exhibit the classic 
triad of cirrhosis, diabetes mellitus and skin 
pigmentatioru 
2. Secondary hemochromatosis — 工 t is a state of iron 
overload, due to the rest of the causes, and usually 
where this cause, such as transfusional overload, or 
absorption from increased amount of dietary iron, can be 
identified. The various causes in association are listed 
in Table 2.2. 
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CHAPTER 3 
ASSESSMENT OF IRON OVERLOAD 
An early diagnosis would be helpful in the management of 
iron overload. Indirect and direct methods are available 
for the assessment of body iron stores. 
3.1 Serum Parameter 
Standard biochemical tests include serum iron, 
transferrin saturation (ratio of serum iron to total iron 
binding capacity) and serum ferritin. „ 
3.1.1 Serum Iron 
Much controversy has been brought forward on the 
reliability of these tests. Serum iron concentration 
shows a diurnal variation with a higher value in the 
morning and lower in the evening. Studies have shown 
that, serum iron has low sensitivity and accuracy for 
positive prediction of iron overload. By itself, it 
provides little diagnostic information ( 117, 118 )• 
3.1.2 Transferrin Saturation 
Transferrin saturation is the ratio of serum iron to 
total iron binding capacity. Several groups have 
evaluated the credibility of transferrin saturation. 
Bassett (118) has found the sensitivity of transferrin 
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saturation to be 82%, the specificity 88%, the accuracy 
for positive prediction 74% and the accuracy for negative 
prediction 93%. A study by Dadone et al (69) suggested 
that a transferrin saturation level above 62% could 
accurately predict 92% of homozygosity of 
hemochromatosis. On the other hand Borwein et al (119) 
and Bassett et al (115) found that a transferrin 
saturation of 55% was the best indication for the 
affected group. 
Despite the high accuracy in assessing iron overload, 
this method has its limitations, as an inflammatory 
disease or infection can supress serum iron, thus 
resulting in low transferrin saturation, whereas, high 
transferrin saturation (>60%) are found in cases of iron 
loading anemia and acute leukemia. False positive results 
are also obtained in non—fasting individuals and when 
samples are drawn at random times (120)• 
Although transferrin saturation is an indirect estimate 
of serum transferrin concentration, any abnormality in 
iron metabolism would first be observed in the change of 
transport iron , therefore, transferrin saturation can 
detect iron overload in the very early course of the 
disease. 
3.1.3 Serum Ferritin 
Serum ferritin can be measured by radioimmunoassays or 
immunoradioinetiric methods. Since serum ferritin is 
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directly proportional to total body iron stored, many 
resarchers recommended it as an index for iron 
deposition. Studies have indicated that serum ferritin 
has correlated well with liver iron concentration (121) 
and mobilizable iron stores by quantitative 
phlebotomy (122). Bassett (118) has demonstrated a 
close association between age and serum ferritin 
concentration. At a given age serum ferritin level rises 
proportionately as age increases and advances at a 
greater rate in hemochromatosis homozygotes, a function 
not found in heterozygotes or homozygous-normal 
individuals. Other studies have shown that besides 
changing with age, serum ferritin is sex related" where 
males have a higher geometric mean ferritin (123, 124, 
125, 126, 127). 
Bassett (118) has also demonstrated that serum ferritin 
had a high sensitivity (85%), specificity (95%), accuracy 
for positive (88%) and negative prediction (94%) in 
screening for hemochromatosis homozygotes. 
However, several studies have pointed out that serum 
ferritin has limitations in detecting iron storage 
disease in young subjects (123, 128, 129, 130). It has 
been postulated that an increase in transport iron 
precedes much earlier than an increase in ferritin level 
(128). 
High concentration of serum ferritin is associated with 
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iron overload, but also liver disease, infection, 
inflammation, or malignancy (131)• 
From the results of various studies (115, 118, 121, 132), 
both transferrin saturation and serum ferritin have 
demonstrated a high degree of sensitivity and specificity 
in the detection of hemochromatosis homozygotes and are 
reliable tests. Serum ferritin concentration has the 
advantage of correlating well with body iron stores, 
however, it has limitations in detecting an increase 
level in young subjects and it reflects only the 
severity of the disease rather than the potential 
liability to disease. On the other hand, transferrin 
saturation is more sensitive and can demonstrate marked 
elevation even early in the course of the disaese (133). 
If only one test is to be used, transferrin saturation 
probably has the edge over that of serum ferritin. In a 
population screening, a combination of transferrin 
saturation and serum ferritin would seem to provide a 
sensitive and effective means for the detection of iron 
overload. 
3-2 Non- serum Parameter 
3.2.1 HLA Tvpina 
HLA typing is a valuable alternative for screening 
hemochromatosis homozygotes and heterozygotes. There is a 
high probability (>95%) of homozygosity for the disease 
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if both HLA haplotypes of the siblings are identical to 
that of the proband, and heterozygosity for the disease 
if only one HLA haplotype is identical (68, 70, 134). 
This method has only to be performed once, however, it is 
expensive, and it can only identify individuals who are 
at risk, but does not reveal the degree of iron loading, 
therefore it is of little diagnostic value. In addition, 
the effect of recombination and homozygous-heterozygous 
mating may produce equivocal results thus render HLA 
typing not 100% reliable (135, 136). 
3.2.2 Hepatic Iron Concentration 
Liver is a major organ for iron storage, it is believed 
that in the development of iron storage disease, iron 
deposits initially in the liver and then later in other 
sites, direct measurement of hepatic iron concentration 
reveals most accurately the iron status of an individual 
and should be considered as the method of reference (13 7, 
138,139, 140). 
Hepatic iron concentration can be determined chemically 
by atomic absorption spectrophotometry or colorometric 
procedure. This method can be used to distinguish between 
patients with iron loading as in the case of alcohol 
liver disease and heterozygotes or homozygotes of 
hereditary hemochromatosis. 
3.2.3 Tissue Parameter 
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In patients with increased level of serum ferritin and 
transferrin saturation, a more definitive test is 
required. Since one of the earliest detectable changes in 
iron overload is an increase in stainable iron, most 
researchers (118, 121, 141) recommended the use of liver 
biopsy as the diagnostic tool. The degree of iron 
deposition can be graded according to the stainable iron 
in parenchymal cells. It enables us to assess the 
degree of fibrosis and cirrhosis, revealing the extent of 
injury. It also allows us to examine the cellular 
distribution of iron. In addition, this test probably 
correlates best with liver iron concentration determined 
chemically. Both liver biopsy and chemical- iron 
concentration provides the best quantitative measures for 
iron status in an individual, however both have the 
disadvantages of associated risk and discomfort which 
makes them a less appealing test to the patient. 
3.2.3(i) Hepatic morphology 
Various grading systems have been introduced for 
assessing hepatic iron which include Scheuer, Conn, 
Brissot, Rowe and Searle. 
Scheuer (142) divided the degree of iron deposition from 
grade 0 to 4, but he did not specify definite guidelines 
as to how to differentiate each grade. Also , he had 
mainly concentrated on hepatocytic iron gradings. 
Conn (84) described another approach where he 
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considered both the degree of iron deposition as well as 
the percentage of cells involved. However, this method 
showed no correlation with iron concentration determined 
chemically. 
Brissot et al. (121), offered a grading system as shown 
in Table 3.2.3. The final grade is obtained by the 
addition of values of H, K, F, in score B (see below), 
where score B is calculated by multiplying a coefficient 
to score A. This complex system also did not introduce 
any specification on how different cell types were graded. 
Table 3.2.3 Brissot's histoloaic crradincr „ 
(Brissot et al., 1981) 
Iron Hepatocytes Kupffer cells Fibrosis 
(H) (K) (F) 
Score A 0-4 0-4 0-4 
coefficient 3 1 1 
Score B 0-12 0-4 0-4 
Total score 0 1-5 6-10 11-15 16-20 
(H+K+F) 
Final grade 0 工 工工 工工工 工• 
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According to Rowe et al. (143), each biopsy was stained 
with routine hematoxylin and eosin and Perls, stain for 
iron. By using various magnifications in the light 
microscope as guideline, he had assigned different 
grades to various degree of stainable iron in the 
hepatocytes, Kupffer cells and biliary epithelium. Each 
specimen was also assessed for the degree of fibrosis, 
fat metamorphosis and other histologic changes. 
Searle et al. (144), took into account the advantages and 
disadvantages of various methods, modified Rowe,s 
procedure and established their own grading system. 
3.2.4 Non-invasive procedure 
A safe and non-invasive procedure by the use of magnetic 
susceptometry for the measurement of hepatic iron stores 
became available. A superconducting quantum interference 
device (SQUID) susceptometer is used to determine the 
change of strength and direction of magnetic response 
evoked by the presence of ferritin and hemosiderin in 
liver tissues under a constant magnetic field (145, 146). 
This method provides a direct, safe, non—invasiveand 
reliable measure for normal or increased storage iron, 
however the instrinnent is not widely available. 
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CHAPTER 4 
METHODS and MATERIALS 
In the study, post mortem liver sections were collected 
from the period of 1987 and surgical liver biopsies were 
from the period of 1984 to 1987. They were all from 
patients of the Prince of Wales Hospital, Shatin, Hong 
Kong. 
Each specimen was stained with routine hematoxylin and 
eosin, (method 1) and Perls' stain (method 2). 
Rowe,s grading system (method 3) was adopted for 
assessing the degree of stainable iron and the eveness of 
distribution in hepatocytes and Kupffer cells in the 
liver sections• Degree of fibrosis, fat metamorphosis, 
presence of macrophage clusters as well as degree of 
stainable iron in the biliary epithelium were also 
examined. This method is chosen as it enables us to 
assess all cell types, and the use of specific 
magnifications to differentiate various degree of 
stainable iron allows an unbiased evaluation. 
Searle's modification (method 4) was also applied in the 
post mortem group and the results compared. 
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All samples were assessed by two readers separately, and 
one hundred samples were reexamined by the same reader 
again on three different occasions to determine the inter 
and intra-observer reproducibility. 
By using an observation from Searle (144), as reference, 
we set the level of normality arbitrarily at 2+ in 
hepatocytes. Any sample which had an iron grading of 
3+ or above in hepatocytes would be considered as 
significant hepatocytic siderosis (SHS). 
In this group of SHS, the clinical history was reviewed 
and features known to be associated with the development 
of iron storage e.g. blood transfusion, hemolytic anemia, 
and liver disease were recorded when available. A more 
extensive evaluation by histological assessment of iron 
in the systemic tissues such as heart, pancreas, bone 
marrow and spleen was followed in the post mortem group 
of patients with and without SHS and in the control 
group. 
Random tissue samples were chosen from each grade of iron 
deposition and the paraffin was removed (method 5). iron 
concentration was determined chemically by atomic 
absorption spectrophotometry (method 6) (137). Iron stock 
solution was used to prepare concentrations of 200uinol/l, 
178uinol/l, 155imol/l, 133uinol/l, llumol/l, 89uinol/l, 
67uinol/l, 44imol/l, 22imol/l, llumol/l and Sumol/l 
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for the standard curve for chemical iron 
determination. The accuracy of the method was assessed by 
assaying two commercial samples containing stated 
concentration of iron. Samples were measured in 
triplicate following procedure in method 6. Values of the 
samples were worked out from the standard curve and the 
percent of error was calculated. For the study of 
precision, unknown samples at different concentration 
levels were used and their iron concentration was 
determined for 10 times. The inter—batch mean, the 
standard devaition and the coefficient of variation were 
calculated. 
In order to assess the effect of paraffin removal on iron 
determination, twelve formalin fixed liver tissues were 
cut into halves, thus forming two sets. One set of these 
twelve samples were processed through paraffin and later 
had the paraffin removed (method 5) • In addition, 9 of 
the paraffin processed tissues were futher divided into 
halves. The set of formalin fixed tissues were dehydrated 
in absolute alcohol as step 6 in paraffin 
o 
removal. All tissues were dried at lio C for three 
hours and liver iron concentration was determined by 
atomic absorption spectrophotometry (method 6). The 
effect of paraffin removal on liver tissue was determined 
statiscally by the t test and the standard deviation was 
calculated for the precision of duplicate measurement on 
hepatic iron concentration. 
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In order to evaluate the results more closely, the total 
population studied was divided into three groups. 
I. Neonates and infants - those with an age less than 
12 months. 
2• Children and adolescence - those with an age ranging 
from 1 to 2 0 years. 
3. Adults - all individuals 21 years of age or over. 
The results of the histological assessment of iron 
stored in the liver were correlated with various 
parameters, including age, sex, degree of fibrosis, 
presence of iron in systemic organs, and chemical 
estimation. This was analysed statistically by logistic 
regression and analysis of variance. 
Patients who were previously well, but died within 48 
hours due to trauma were selected as the control group, 
and their iron status in the liver and systemic tissues 
were studied as above. 
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METHOD 1 
Haematoxylin and Eosin stain (147) 
Material : 
1. Harris's haematoxylin 
2. 1% (V/V) acid-alcohol 
cone HCl 1 cm^ 
70% alcohol 100 cm^ 
3. 1% (W/V) eosin in 1% (W/V) calcium chloride 
4. Scott's water substitute 
Method : 
1. Take sections to water. 
2. Stain in Harris's haematoxylin for 20 minutes. 
3. Wash in water and blue in Scott's tapwater 
substitute. Examine microscopically to confirm 
sufficient degree of staining. 
4. Remove excess stain from cytoplasm by differentiating 
in acid alcohol for 10-20 seconds. 
5. Wash in water. 
6. Regain the blue colour by treating with Scott,s 
tapwater substitute. Check microscopically to make 
sure only the nuclei are stained. 
7. Wash in water for 1 minute. 
8. Stain in 1% eosin for 1 minute. 
9. Rinse quickly in water. 
10. Differentiate eosin in 70% alcohol. 
11. Dehydrate, clear and mount. 
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METHOD 1 
Perls' Prussian Blue Method(148) 
Material : 
Perls' Reagent : 
Solution A : 2% Hydrochloric acid 
Solution B : 2% Potassium Ferrocyanide 
Neutral Red : 1% aqueous solution 
Procedure : 
1. Bring section to water. 
2. Rinse with distilled water. 
3. Treat with equal parts of solution A and B for 25 
minutes. 
4. Wash in distilled and tap water. 
5. Counterstain nuclei with neutral red for 5 minutes. 
6. Dehydrate, clear and mount. 
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METHOD 1 
Rowe,s Grading System of Iron Deposition(143) 
Degree of visibility of iron 
Maqnification Hemosiderin in Perls^ stain Grading 
430X visible trace 
430X easily visible 1+ 
250X barely visible 1+ 
250X easily identified 2+ 
50X easily identified 3 + 
lOX easily identified 4 + 
Macroscopically blue 4 + 
Note: for convenience, we used X4 0 magnification, so our 
conditions were slightly more stringent. 
Fat content 
0 - none 
1+ - fat vacuoles in less than 2 hepatocytes/low power 
field. 
2+ — scattered fat accumulation recognisable in every 
low power field. 
3+ - fat vacuoles in at least 75% of the hepatocytes. 
4+ — fat vacuoles in over 90% of the hepatocytes. 
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Fibrosis 
0 一 none 
trace - collagen confined to the space of Disse. 
1+ 
一 denote lesser degree of portal & lobule fibrosis. 
2 + 
3+ — diffuse increase in portal and lobular connective 
tissue but insufficient in amount on distribution 
to qualify as cirrhosis. 
4+ — frank cirrhosis with fibres bridging of lobules 
and central portal areas. 
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METHOD 1 
Searle's Grading System of Iron Deposition(144) 
Degree of visibility of 
Grading Hemosiderin in Perl's stain Maqnificat土cm 
0 Granules absent or barely discernible X400 
1+ Barely discernible X250 
Easily confirmed X400 
2+ Discrete granules resolved XlOO 
3+ Discrete granules resolved X25 
4+ Masses visible XIO 




1. Remove section from paraffin blocking by immersing 
block in paraffin at C. 
2. Take section to xylene overnight with continuous 
agitations. 
3. Take section to hexane overnight with continuous 
agitations• 
4. Repeat step 3 once. 
5. Dehydrate in absolute alcohol for 6 hours. 




1- Weigh the dried liver section. 
2. Each specimen is wet-ashed in 1 ml of concentrated 
nitric acid* 
3. Boil in boiling water bath until tissue is totally 
dissolved. 
4. After cooling, the wet-ashed sample is transferred to 
a 5 ml volumetric flask and made up to volume with 
deionized distilled water. 
5. Use concentrated iron stock solution to prepare iron 
standard solutions. 
6. Iron concentration of the sample is measured by 
Varian Techtron atomic absorption spectrophotometer 
operated with acetylene/air mixture. 
7. Cathode lamp current used is 5 mA and wavelength is 
set at 248.3 nm and a slit width of 0.2 nm. 
8. Absorbance of the samples was taken and the iron 




The studied group consisted of 734 patients with no 
duplication,• 442 were surgical biopsies, 240 were post 
mortem liver sections and 52 were from neonates 
(including 48 autopsy and 4 surgical cases )• Twenty-two 
patients with traumatic death as defined previously were 
selected as the control group. 
5.1 Chemical Determination 
Livei: iron concentration was estimated by the use of 
Varian atomic absorption spectrophotometer ( model 1 4 7 5 ) 
A standard curve was set up by using iron standards and 
values of the samples were obtained from the curve. The 
accuracy of the method was assessed by assaying two 
commercial samples containing stated concentration of 
iron. The mean and percentage of error were determined. 
For the study of precision, unknown samples were used 
instead. The mean, standard deviation and the 
coefficient of variation were calculated. Results for 
accuracy and precision of the method are shown in Table 
5.1.1. 
Table 5.1.2(i) illustrates results on hepatic iron 
concentration on tissues fixed in formalin and paraffin 
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embedded samples with paraffin removed. By using t test, 
the effect of paraffin removal on iron in liver tissues 
was found to be insignificant. Table 5.1.2(ii) shows 
results on duplicate measurement of liver specimens after 
paraffin processing and removal. The standard deviation 
was found to be 土 2 . 1 1 umol/g dry weight and the 
precision of the duplicate measurement was acceptable. 
liiver tissues were processed following the procedure 
of method 5, and their iron concentrations were measured. 
One hundred random samples which include 90 from the post 
mortem group and 10 from the control were chosen 
initially, however 3 samples were spoiled during the 
process. Moreover, due to insufficient samples from 
patients who had 1+ iron grading in hepatocytes, only 4 
samples from this grade were studied. These results are 
shown in Table 5.1.3. The iron concentrations obtained 
ranged from 2.6 umol/g dry weight to 435 
umo1/g dry weight• 
In the autopsy group, among the 87 patients studied, 
18 ( 20.7% ) had an iron concentration above 40 umol/g 
dry weight, which is the cut off point for significant 
iron concentration ( 145 ) • The mean age of these 18 
individuals was 61. Of the 16 individuals which had a 4+ 
iron deposition in hepatocytes, 13 ( 81.3% ) had an 
elevated iron concentration. On reexamination of the 
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histologic samples with discrepant results, the 2 
specimens which had a low hepatic iron concentration were 
found to contain largely of tumor. Of the 2 2 persons 
which had a 3+ iron accumulation in hepatocytes, 
only 4 (18.1%) showed an increase in liver iron 
concentration. Fibrosis, cirrhosis or tumor were 
present in all samples which had an iron concentration 
below the significant threshold in this group. Of the 
26 cases which had a 2+ iron grading in 
hepatocytes, 1 (3.8%) revealed an iron concentration 
above 40 umol/g dry weight. All specimens from the 
0 and 1+ iron gradings exhibited an iron concentration 
within the normal range. 
Furthermore, among the 18 patients who had a high 
chemical liver iron concentration, 13 ( 72.2% ) were male 
and 5 ( 27.8% ) were female. 
The histological pattern of distribution of iron in these 
individuals with significant iron concentration estimated 
chemically were either periportal or diffused. Six had 
iron deposition predominantly around the periportal 
region and 12 exhibited iron accumulation diffusely 
throughout the lobule. Iron deposition was also present 
in the Kupffer cells of all these specimens. 
Figure 1 shows the distribution of patients with 
different chemical iron concentrations in various 
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hepatocytic iron gradings. 
By using analysis of variance, various gradings of iron 
deposition on hepatocytes was significantly correlated 
with chemical iron concentrations ( p= 0.014 ), thus the 
histological procedure is validated for assessing 
hepatocytic iron content. 
5.2 Control Group 
We reviewed the clinical history of the post mortem 
group, and selected 22 patients who were previously well 
but had died within 48 hours due to trauma as our control 
group. Degree of stainable iron in hepatocytes, Kupffer 
cells, systemic tissues, as well as the presence of 
macrophage clusters, presence of iron in biliary 
epithelium and presence of fibrosis were assessed. 
Results of this group of patient are summarized in Tables 
5.2.1, 5.2.2, 5.2.3 and 5.2.4. 
The age distribution in the control group ranged from 4 
to 88 with a mean age of 46 years. Among the 22 patients, 
6 ( 27.3% ) were female and 16 ( 72.7% ) were male. We 
found that 9 of the 22 ( 40.9% ) patients in the adult 
group had 3+ or 4+ hepatocytic siderosis, and of these 
9 subjects, 5 ( 55.6% ) showed systemic iron deposition, 
including pancreas and myocardium. Five of the 9 
patients ( 22.7% of the total group ) had a mixed 
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pattern of iron deposition in both hepatocytes and 
Kupffer cells, while 4 ( 18.2% of the total group ) 
patients had iron predominantly in hepatocytes. Only 
one of the two patients in the group with 4+ iron 
deposition in hepatocytes showed elevated iron 
concentration by chemical method. All patients with 0, 
1+, 2+ and 3+ iron grading had normal iron concentration. 
Many had had transfusion, but by definition, they 
were within 48 hours prior to death. 
5.3 Histological Study 
Estimation of iron in hepatic parenchymal cells 
(Fig. 2A, 2B, 2C, 2D, 2E ) and Kupffer cells ( Fig. 3A, 
3B, 3C ) was assessed according to the visibility of blue 
iron granules under different magrdfications• Different 
patterns of iron distribution, such as diffuse ( Fig. 4), 
focal ( Fig.2C ), periportal ( Fig. 5A, 5B ) and mixed 
pattern ( Fig.6A, 6B ) with iron deposited in both 
hepatocytes and Kupffer cells were noted. other 
histological features including presence of macrophage 
clusters ( Fig. 3C ), and presence of iron in biliary 
epithelium ( Fig. 7 ) were recorded. 
The assessment was performed separately by two readers 
and 100 samples were reexamined by the same reader again 
later. The intraobserver and interobserver 
repiroducibility were found to be 92% and 89% 
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respectively. Only small variation, never more than 1 
grade discrepancy was noted. Disagreement was usually 
found in samples with an iron deposition of 1+ or 2 + 
which were not considered as significant. Since a 2 + 
iron grading may occasionally be found in patients with 
a tissue iron concentration at the normal upper limit, 
only a 3+ or higher iron grading in hepatocytes would 
be considered as significant• 
The term significant hepatocvtic siderosis (SHS) used in 
this thesis is based upon this criterion. 
5.3.1 Neonates and Infant ( Table 5.3.1 ) 
In the neonatal group, a total of 52 specimens were 
examined, of which 48 were post mortem samples and 4 were 
surgical biopsies. In the post mortem group, 2 5 neonates 
(52.1% ) ( Fig. 8 ) were found to have 3+ or 4 + 
parenchymal iron deposition. Among these 25 cases, 9 
(36.0%) were known to have congenital hemolytic anemias, 
the remainder had not been tested for this disorder. 
In the surgical group of the neonates, 2 ( 50% ) 
(Fig.8 ) had 3+ iron grading in the hepatocytes. 
Positivity of iron in Kupffer cells is shown in 
Fig. 9. In the autopsy group, 16 neonates (33.3%) had 
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3+ and 2 (4.2%) had 4+ iron deposited in the Kupffer 
cells. In the surgical group, 2 neonates (50.0%) had 3+ 
or 4+ iron accumulation in the Kupffer cells. 
5.3.2 Children and Adolescence ( Table 5.3.2 ) 
Forty specimens were examined for iron deposition in the 
liver in this young children and adolescence group. It 
comprised of patients with an age ranging from 1 
to 2 0 years. In the post mortem group, 1 patient 
( 7 . 7 % ) had 3+ iron grading in the hepatocytes, and in 
the surgical group, 1 person ( 3.7% ) had 4+ iron, 
whereas 2 individuals ( 7.4% ) had 3+ iron deposition in 
the hepatocytes. ( Fig.10 ) 
Three Patients ( 23.1% ) had 3+ iron accumulation in 
Kupffer cells in the autopsy group and 1 patient 
( 3 . 7 % ) had 4+ and another 1 person (3.7%) had 3+ iron 
deposition in Kupffer cells of the surgical group. 
(Fig. 11) 
5.3.3 Adult Iron Storage ( Table 5.3.3 ) 
The adult group , consisted of patients who were 21 
years of age or over. A total of 642 samples were 
studied. Eighty—eight of 227 patients ( 38.8% ) in the 
autopsy group, and 128 of 415 patients ( 30.8% ) in the 
surgical group had 3+ or 4+ iron accumulation in 
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hepatocytes. (Fig. 12) 
As for 3+ or 4+ iron grading in Kupffer cells, 59 
( 2 6 . 0 % ) , and 79 ( 19.1% ) were found in the post 
mortem group and surgical group respectively. (Fig.13) 
In the adult group, histological gradings in 46 of the 55 
cases which had multiple tissue sections were identical, 
7 had 1 grade difference and 2 had two grades difference. 
The two samples with a variation of 2 grades had some 
sections containing predominately of normal tissues and 
some largely with tumor. Iron was found in the functional 
liver tissues but not in the tumor. 
5.4 Sex Distribution 
Table 5.4 shows results of positivity of iron deposition 
in parenchymal hepatocytes of the two sexes. Among the 
442 patients in the surgical group, 296 ( 67.0% ) 
were male and 100 ( 33.8% ) of these had 3+ or 4+ iron 
accumulation in the hepatocytes; 146 ( 33.0% ) were 
female, and 31 ( 21.2% ) had significant iron grading 
in the hepatocytes. ( Fig.14 ) 
In the autopsy group, there were 136 males and 104 
females of which 53 of the male ( 39.0% ) and 36 of 
the female ( 34.6% ) were found to have 3+ or 4 + 
siderosis in the hepatocytes. (Fig. 14) 
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The sex parameter was not significant when correlated 
with hepatocytic iron deposition ( p= o.1590 )• 
5.5 Age Distribution 
Table 5.5, Fig.15, Fig. 16 show the distribution of 
patients with various hepatocytic iron gradings (from 
both surgical and autopsy liver cases ), in different age 
groups. The mean age of the post mortem group is 63 
years, the surgical group is 51 years , whereas the mean 
age of the total population is 55 years. 
By analysis of variance, age was correlated significantly 
with iron deposition in hepatocytes for the autopsy group 
( p = 0.0036 ), the surgical group ( p=0.0008 ), however, 
not for the control group ( p=0.28 )• 
5.6 Association Between Siderosis in Hepatocytes and 
Kupffer Cells 
Table 5.6, Fig.17 shows the association between 
distribution of iron siderosis in hepatocytes to that 
in the Kupffer cells, 11 patients ( 4.5% ) in the 
autopsy group and 16 patients ( 3.5% ) in the surgical 
group had a pattern of SHS with dominant hepatocytic iron 
accumulation. Sixteen patients ( 6.6% ) in the post 
mortem group and 18 patients ( 4.0% ) in the surgical 
group had iron deposition of 3+ or 4+ predominantly in 
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the Kupffer cells. Seventy—eight ( 32.5% ) of the post 
mortem patients had significant hepatocytic 
siderosis with a mixed pattern, i.e. 3+/4+ iron in 
hepatocytes with 2+/3+/4+ iron in the Kupffer cells and 
115 ( 26.0% ) of the patients in the surgical group had 
SHS with a mixed pattern. 
5.7 Association of Hepatocytic Iron with Fibrosis 
Table 5.7 shows the relationship between iron deposition 
in hepatocytes to various degree of fibrosis. We found 
that the extent of fibrosis was not directly proportional 
to the severity of iron accumulation, and statistically 
not significant ( p=0.378 )• 
5.8 Systemic Tissues 
In the adult group of patients with 0, 3+ or 4 + 
hepatocytic siderosis, we did a more extensive study by 
evaluating the iron status in systemic tissues, 
specifically including myocardium, bone marrow, spleen 
and pancreas, where such tissues were available. 
Tissue sections were stained by the Perls, method 
(method 2) and the degree of stainable iron was assessed. 
Table 5.8. illustrates the results of patients with 
significant hepatocytic siderosis in relation to various 
degree of siderosis in the systemic tissues. 
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Thirteen patients with 4+ iron grading were studied, 
however, some organ tissues were not available. We found 
that, of the 12 patients who had 4+ iron in the 
hepatocyte, 8 ( 66.6% ) had myocardial siderosis and 10 ( 
83.3% ) had pancreatic siderosis. Of the 10 patients who 
had bone marrow examined, 8 (80.0%) had iron deposition 
and all of the 11 patients ( 100% ) where spleenic 
tissues were studied showed iron accumulation. Among the 
3 6 patients who had a lesser degree of hepatocytic iron 
(3+ iron grading) , 8 of the 36 patients (22.2%) were 
found to have iron present in the myocardium and 
another 8 of the 34 patients ( 23.5% ) revealed iron 
deposition in the pancreas. As for bone marrow, 31 of the 
32 patients ( 96.6% ) had iron accumulation and all 33 
spleenic samples studied showed siderosis. 
In the group of patients who had no iron accumulation in 
the liver, only 3 of the 49 patients ( 6.1% ) were found 
to have siderosis in the myocardium but no patient was 
found to have iron deposition in the pancreas. Fewer 
number of patients with iron accumulation in bone marrow 
and spleen were found in this group. Only 17 of the 40 
patients (42.5%) had siderosis in the bone marrow and 32 
of the 46 patients (70.0%) had spleenic iron deposition. 
In addition, we were able to follow up the clinical 
history of 21 surgical cases who had 4+ iron grading in 
the hepatocytes. It was found that 5 ( 23.8% ) cases had 
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diabetes mellitus, 4 ( 19.0% ) had thalassemia ( 3 beta 
and 1 alpha ), 10 ( 47.6% ) had hepatocellular carcinoma 
as concommitant disease and the other 2 cases had no 
disease relevant to iron storage. Nineteen out of twenty— 
one cases did have a disease which could be associated 
with iron overload. 
Figure 18 illustrates the distribution of siderosis in 
myocardium and pancreas in patients with 0, 3+ and 4 + 
hepatocytic iron in the autopsy group and patients with 
3+ and 4+ iron accumulation in hepatocytes in the control 
group. 
By using logistic regression, hepatocytic iron 
accumulation was correlated significantly with iron 
deposition in myocardium ( p<0.001 ), bone marrow ( 
p<0.001) and pancreas ( p< 0.001 )• However, there was no 
convergence with spleen. 
5.9 Liver Tissue Assessed by a Second Histologic Method 
In order to further validate the results of significant 
heptocytic siderosis, we have adopted Searle,s 
modification (method 4) as a counter check on this group 
of patients. 
Searle's method is more stringent, as the criteria set 
for a 3+ iron grading involves presence of discrete 
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granules under 25x magrdfication. This magnification is 
lower than that set by Rowe's m e t h o d . Since we are 
primarily concerned with the group of patients exhibiting 
significant heptocytic siderosis, we have only reexamined 
specimens with a 3+ or above iron grading obtained from 
Rowe's method using this guideline. 
Table 5.9 shows results of the histological grading of 
3+ and 4+ iron in hepatocytes and Kupffer cells in the 
autopsy group. Sixty—nine (30.3%) of the 227 patients 
in the adult group showed significant hepatocytic 
siderosis in the hepatocytes, however, no patient was 
found to have significant iron deposition in the 
adolesence group. Forty—nine patients ( 21.6% ) in the 
adult group had 3+ or 4+ iron and 3 patients (23.1%) in 
the adolesence group had 3+ iron deposition in the 
Kupffer cells. 
Comparison of patients with different hepatocytic iron 
gradings as assessed by Rowe,s and Searle,s histologic 
method is shown in Fig. 19. 
When we correlate this set of results with iron 
concentration determined by chemical method, we found 
that 13 of the 16 patients ( 81.3% ) who had 4+ iron 
deposition in hepatocytes had an iron concentration 
over 40 umol/g dry weight. Four of the 20 
individuals ( 20.0% ) who had 3+ iron grading in 
hepatocytes showed an elevation in iron concentration. 
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5.1.1 (i) Accuracy of atomic absorption 
spectrophotometry 
Expected iron “ — 






of triplicate 86.6 24.8 
measurement 
(umol/l) 
% error = 
Iron con'c — expected 
value 
X 100% 2.47% -12.7% 
Expected value 
(ii) Within batch precision of atomic absorption 
spectrophotometry 
Iron concentration of unknown samples (umol/l) 
讯ean 13.6 25.1 106.4 
(n=9) 
standard 土1.1 土1.0 土6.19 
deviation — 
coefficient 
of 8.3% 4.1% 5.8% 
variation 
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"^able 5.1.2 (i) Concentration of iron determined by 
atomic absorption spectrphotometry in liver specimens 
fixed in formalin and paraffin embedded tissues 
Hepatic Iron Concentration (umol/g dry weihgt) 
Sample Formalin fixed Paraffin embedded 
tissues tissues* 
1 9.0 9.4 
2 23.9 25.9 
3 17.6 14.8 
4 23.6 24.5 
5 22.9 18.8 
6 23.0 18.7 
7 22.8 16.8 
8 13.5 12.7 
9 21.1 17.4 
10 14.3 12.7 
11 40.3 39.4 
12 5.0 6.3 
(ii) Duplicate measurement of paraffin processed and 
removed tissues 
Hepatic iron concentration (umol/ g dry weight) 
Difference in 
Sample 1st reading 2nd reading duplicate 
measurement 
1 9.4 10.2 -0.8 
2 25.9 26.7 -0.8 
3 14.8 15.3 -0.5 
4 24.5 20.0 4.5 
5 18.8 16.7 2.1 
6 18.7 17.4 1.3 
7 16.8 17.9 -1.1 
8 12.7 14.2 -1.5 
一 f 17^4 15.3 2.1 
Standard deviation =土 2.11 
* paraffin embedded tissues with paraffin removed by hexane 
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5.1.3 Comparison of hepatic iron concentration 
determined by atomic absorption spectrophotometry in 
liver tissues with histoloaical iron cfrad土nqs in the 
autopsy cfroup. 
Hepatocytic iron gradings 
0 1+ 2+ 3+ 4 + 
C 10.9 19.0 31.5 37.5 48.0 
H 24.8 22.0 38.7 18.3 56.0 
E 12.6 9.1 24.4 3.8 46.1 
M 2.2 17.5 3.0 6.7 238.0 
工 3 2 . 5 3 2 . 9 3 5 . 5 4 3 5 . 0 
C 6.5 23.5 21.4 80.4 
A 9.2 14.2 34.4 2.6 
L 7.2 27.7 24.9 76.0 
17.0 21.1 28.2 12.4 
I 17.2 19.7 17.9 70.2 
^ 13.5 17.8 58.3 52.4 
0 3.2 17.2 30.3 42.4 
N 20.2 22.3 20.7 40.1 
11-5 17.8 30.0 103.9 
C 6.1 19.3 61.3 93.0 
O 12.7 12.2 24.3 65.5 
N 19.1 19.6 21.3 
C 21.4 26.2 27.9 
E 17.8 12.2 69.6 
N 29.9 32.7 
T 27.6 20.2 
^ 35.2 51.5 
A 45.9 
T 31.2 
工 2 1 . 2 
O 26.4 
n 
iron concentration in umol/g dry wt. 
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Table 5.2.1 Iron cfradinqs in Hepatocytes and Kupffer 
cells of the control group. 
HEPATOCYTE 
0 1+ 2+ 3+ 4+ SUBTOTAL 
K 0 5 0 4 4 0 13 
U 
P l + 0 2 0 0 0 2 
F 
F 2+ 0 0 2 2 2 6 
E 
R 3+ 0 0 0 1 0 1 
4+ 0 0 0 0 0 0 
SUBTOTAL 5 2 6 7 2 2 2 
(TOTAL) 
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Table 5.2.2 Hepatocytic iron qradincfs in different age 
groups of controls 
1-10 21-30 41-50 61-70 
11一20 31-40 51-60 >71 
H 
E O 2 0 0 0 0 1 1 1 
P 
A 1+ 0 1 0 1 0 0 0 0 
T 
0 2+ 0 2 1 0 0 2 1 0 
C 
Y 3+ 0 0 0 2 2 1 0 2 
T 
E 4+ 0 0 0 0 0 0 1 1 
SUBTOTAL 2 3 1 3 2 4 3 4 2 2(TOTAL) 
p value for correlation of age with hepatocytic iron 
gradings in the control group =0.28 
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Table 5.2.3 Chemical determination of iron content in 
liver tissues with various histologic iron 
qradinqs in the control group. 
HEPATOCYTIC IRON GRADING 
0 1+ 2+ 3+ 4 + 
C 
H I C 
E 11.0 13.8 29.4 33.0 40.2 
M R O 
工 7 . 2 23.2 22.4 36.8 134.6 
C O N 
A 
L N C 
iron concentration in umol/g dry weight. 
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Table 5.2.4 Systemic iron deposition in patients of 
the control group 
Myocardium Bone marrow Spleen Pancreas 
Patients 
with 
4+iron 1/2(50.0%) 2/2 (100%) 2/2(100%) 2/2(100%) 
grading 
3+ iron 1/7(14.2%) 6/6 (100%) 2/2 (100%) 2/5 (40.0%) 
grading 
(i) 
patients with Degree of siderosis 
4+ iron 
grading 0 1+ 2+ 3+ 4+ 
Myocardium 1 1 0 0 0 
(50.0%) (50.0%) (0.0%) (0.0%) (0.0%) 
Bone marrow 0 1 1 0 0 
(0.0%) (50.0%) (50.0%) (0.0%) (0.0%) 
Spleen 0 0 0 1 i 
(0.0%) (0.0%) (0.0%) (50.0%) (50.0%) 
Pancreas 0 1 1 0 0 
(0.0%) (50.0%) (50.0%) (0.0%) (0.0%) 
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(ii) 
patients with Degree of siderosis 
3+ iron 
grading 0 1+ 2+ 3+ 4+ 
Myocardium 6 1 • 0 0 
(85.7%) (14.3%) (0.0%) (0.0%) (0.0%) 
Bone marrow 0 0 4 2 0 
(0.0%) (0.0%) (66.7%) (33.3%) (0.0%) 
Spleen 0 0 1 0 1 
(0.0%) (0.0%) (50.0%) (0.0%) (50.0%) 
Pancreas 3 1 1 0 0 
(60.0%) (20.0%) (20.0%) (0.0%) (0.0%) 
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Fig. 2A Illustrates 1+ iron grading, evenly distributed 
in hepatocytes. By Perls' stain; x460 magnification. 
Fig. 2B Illustrates 2+ iron deposition predoininantly in 
hepatocytes. By Perls' stain; x230 magnification. 
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Fig. 2C Illustrates presence of 3+ hemosiderin granules 
with focal deposition in hepatocytes. It also 
demonstrates cholestasis. By Perls‘ stain; x65 
magnification. 
Fig* 2D The section shows 3+ iron deposition in 
hepatocytes with accumulation heavier in areas. By Perls' 
stain; xl65 magnification. 
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Fig. 2E Illustrates an uneven distribution of 4+ 
hemosiderin granules in hepatocytes. By Perls' stain; x65 
magnification• 
Fig. 3A It shows an uneven distribution of 1+ iron 













































































































































































Fig. 3B Illustrates an even distribution of 3+ iron 
grading predominantly in the Kupffer cells. By Perls' 
stain,• xl65 magnification. 
Fig. 3C Shows an uneven distribution of 3+ iron grading 
in Kupffer cells with macrophage clusters. By Perls' 
stain; X165 magnification. 
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Fig. 4 Illustrates a diffuse pattern of 2+ hemosiderin 
granules in hepatocytes. By Perls, stain; xl65 
magnification. 
Fig. 5A The section shows 3+ hepatocytic iron 
deposition in the neonate, predominantly in the 
periportal region. By Perls, stain/ xl65 magnification. 
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Fig. 5B Illustrates 3+ hepatocytic iron, predominantly 
in the periportal area in an adult. It also reveals iron 
granules in the biliary epithelium. By Perls' stain; xl65 
magnification. 
Fig. 6A Illustrates presence of 2+ hemosiderin granules 
in both hepatocytes and Kupffer cells. It shows a mixed 
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Fig. 6B This section shows 4+ iron grading in both 
hepatocytes and Kupffer cells with deposition heavier in 
areas. It demonstrates a mixed pattern of uneven 
distribution. By Perls' stain; xl65 magnification. 
Fig. 7 Shows the presence of hemosiderin granules in 
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Table 5.3.1 Distribution of hepatic iron gradings in 
neonates.(group 1) 
HEPATOCYTE 工RON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ Total 
GROUP 
18 0 5 21 4 48 
(37.5%) (0.0%) (10.4%) (43.8%) (8.3%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
1 0 1 2 0 4 
(25.0%) (0.0%) (25.0%) (50.0%) (0.0%) 
KUPFFER CELL IRON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
19 0 11 16 2 48 
(39.6%) (0.0%) (22.9%) (33.3%) (4.2%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
1 0 1 2 0 4 
(25.0%) (0.0%) (25.0%) (50.0%) (0.0%) 
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IRON GRADINGS IN HEPATOCYTES IN NEONATES 








50X - ^ ^ 
* ：一 
：推. 
0 1+ 2+ 3+ 
HEPATOCYTIC IRON GRAOmCS 
I V 1 AUTOPSY NEONATES W 2 SURGICAL NEONATES 
F i g . 8 
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IRON' 6RADINGS IN KUPFFER CELLS IN NEONATES 






‘ ； I J L 
U 力 \ I I 
0 1+ 2+ 3+ 4+ 
KUPFFER CELL IRON GRADINGS 
E D AUTOPSY KEOKATES SURGICAL NEONATES 
Fig. 9 
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Table 5.3.2 Iron gradings in the children and adolescence 
group. X group 2 
HEPATOCYTE IRON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
10 0 2 1 0 13 
(76.9%) (0.0%) (15.4%) (7.7%) (0.0%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
15 4 5 2 1 27 
(55.6%) (14.8%) (18.5%) (7.4%) (3.7%) 
KUPFFER CELLS 工RON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
9 0 1 3 0 13 
(69.2%) (0.0%) (7.7%) (23.1%) (0.0%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
18 2 5 1 1 27 
(66.7%) (7.4%) (18.5%) (3.7%) (3.7%) 
96 
.； 
GROUP 2 ( ADOLESCENCE GROUP ) PATIENTS WITH DIFFERENT 





w \ \ 
-Hi J 
0 1+ 2+ 3+ 4+ 
HEPATOCYTIC IRON GRADINGS 
V I AUTOPSY GROUP V H SURGICAL GROUP 
F i g . 10 
97 
GROUP 2 ( ADOLESCENCE GROUP ) PATIENTS WITH DIFFERENT 





::耀 ^ m p . 
0 1+ 2+ 3+ 4+ 
KUPFFER CELL IRON GRADINGS 
V I AUTOPSY GROUP ^ SURGICAL GROUP 
F i g . 1 1 
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Table 5.3.3 Iron qradinqs of the adult group 丄 group 3 丄 
HEPATOCYTE IRON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
63 6 70 72 16 227 
(27.8%) (2.6%) (30.8%) (31.7%) (7.1%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
205 10 72 101 27 415 
(49.4%) (2.4%) (17.4%) (24.3%) (6.5%) 
KUPFFER CELLS IRON GRADING 
AUTOPSY 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
85 11 72 55 4 227 
(37.4%) (4.9%) (31.7%) (24.2%) (1.8%) 
SURGICAL 0 1+ 2+ 3+ 4+ TOTAL 
GROUP 
211 23 102 75 4 415 
(50.9%) (5.5%) (24.5%) (18.1%) (1.0%) 
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DISTRIBUTION OF GROUP 3 ( ADULT GROUP ) PATIENTS WITH 
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0 1+ 2+ 3+ 4+ 
IIEPATOCYTE IRON GRADINGS 
\ n AUTOPSY GROUP ^ SURGICAL GROUP 
Fig. 12 
86 
DISTRIBUTION OF GROUP 3 ( ADULT GROUP ) PATIENTS WITH 
VARIOUS IRON GRADINGS IN KUPFFER CELL 
9 








< 50% - nri 
： 0 
0 1+ 2+ 3+ 4+ 
KUPFFER CELL IRON GRADINGS 
\~L AUTOPSY GROUP ^ SURGICAL GROUP 
Fig. 12 
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Table 5.4 Distribution of patients with significant 
hepatocvtic siderosis in males & females. 
SURGICAL MALE FEMALE TOTAL 
GROUP 
NO. OF PATIENTS 296 14 6 442 
(67.0% ) ( 33.0% ) 
NO. OF PATIENTS 100 31 
WITH SHS 
(33.8% ) ( 21.2% ) 
AUTOPSY MALE FEMALE TOTAL 
GROUP 
NO. OF PATIENTS 136 104 240 
(56.7% ) ( 43.3% ) 
NO. OF PATIENTS 53 3 6 
WITH SHS 
(39.0% ) ( 34.6% ) 
p value for correlation between sex and hepatocytic 
gradings =0.1590 
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仏 b l e 5.5 Hepatocytic iron qradinas in various age 
groups of patients.• 
AUTOPSY AGE GROUPS 
1-10 21-30 41-50 61-70 TOTAL 
11-20 31-40 51-60 >71 
H O 4 6 3 6 3 10 15 26 73 
E 
P 1+ 0 1 1 0 1 2 2 0 6 
A 
T 2+ 1 1 2 4 3 10 23 28 72 
O 
C 3+ 1 0 2 2 5 7 14 42 73 
Y 
T 4+ 0 0 0 0 3 3 3 7 16 
E 
TOTAL 6 7 8 12 15 32 57 103 240 
SURGICAL AGE GROUPS 
1-10 21-30 41-50 61-70 TOTAL 
11-20 31-40 51-60 >70 
H 0 5 10 32 33 27 38 46 29 220 
E 
P 1+ 2 2 5 0 1 2 1 1 14 
A 
T 2+ 2 3 7 18 12 11 10 14 77 
O 
C 3+ 2 0 4 13 10 31 22 21 103 
Y 
T 4+ 0 1 2 2 3 6 10 4 28 
E 
TOTAL 11 16 50 66 53 88 89 69 442 
p value for correlation age and hepatocytic iron gradings 
Autopsy group p=0.0036 
Surgery group p=0.0008 
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DISTRIBUTION OF PATIENTS WITH VARIOUS HEPATOCYTIC 
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DISTRIBUTION OF PATIENTS WITH VARIOUS HEPATOCYTIC 
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0 1+ 2+ 3+ 4+ SUBTOTAL 
K 0 58 4 22 10 1 95 
U 
P 1+ 6 0 4 0 0 10 
P 
F 2+ 8 2 31 30 2 73 
E 
R 3+ 1 0 13 31 13 58 
4+ 0 0 2 2 0 4 




0 1+ 2+ 3+ 4+ SUBTOTAL 
K 0 196 4 19 10 0 229 
U 
P 1+ 4 4 11 6 0 25 
F 
F 2+ 20 6 29 47 5 107 
E 
R 34- 0 0 18 39 19 76 
4+ 0 0 0 1 4 5 
SUBTOTAL 220 14 77 103 28 442 
(TOTAL) 
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PATIENTS WITH DIFFERENT IRON GRADINGS IN HEPATOCYTES 
AND KUPFFER CELLS 
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Table 5•7 Patients with various hepatocvtic iron gradings 
in relation to different degree of fibrosis. 
AUTOPSY 
FIBROSIS 
0 1+ 2+ 3+ 4+ SUBTOTAL 
H O 30 18 17 5 3 73 
E 
P 1+ 1 1 4 0 0 6 
A 
T 2+ 36 14 13 7 2 72 
0 
C 3+ 38 12 13 6 4 73 
Y 
T 4+ 2 0 2 8 4 16 
E 




0 1+ 2+ 3+ 4+ SUBTOTAL 
H 0 190 6 3 12 9 220 
E 
P 1+ 10 0 2 1 1 14 
A 
T 2+ 33 10 13 13 8 77 
O 
C 3+ 21 11 17 33 21 103 
Y 
T 4+ 6 3 5 8 6 28 
E 
SUBTOTAL 260 30 40 67 45 442 
(TOTAL) 
p value for correlation of degree of fibrosis with 
hepatocytic iron gradings =0.378 
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Table 5.8 Systemic iron deposition in patients with 
different decrree of parenchymal siderosis. 
(i) Various degree of siderosis in different systemic 
organs in patients with 4+ iron deposition in 
hepatocytes. 
Myocardium Bone Marrow Spleen Pancreas 
No. of 
patients 
(+/total) 8/12 8/10 11/11 10/12 
percentage (66.6%) (80.0%) (100%) (83.3%) 
Degree of siderosis 
* NS 0 1+ 2+ 3+ 4+ TOTAL 
Myocardium 1 4 6 1 0 1 12 
(33.3%)(50.0%) (8.3%)(0.0%)(8.3%) 
Bone marrow 3 2 1 3 4 0 10 
(20.0%) (10.0%) (30.0%) (40.0%) (0.0%) 
Spleen 2 0 0 6 3 2 11 
(0.0%) (0.0%) (54.5%) (27.2%) (18.2%) 
Pancreas 1 2 1 4 5 0 12 
(16.7%) (8.3%) (33.3%) (41.7%) (0.0%) 
* NS = No specimen 
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Table 5.8 
(ii) Various degree of siderosis in different 
systemic organs in patients with 3+ iron gradings in 
hepatocytes. 
Myocardium Bone Marrow Spleen Pancreas 
No. of 
patients 
(+/total) 8/36 31/32 33/33 8/34 
percentage (22.2%) (96.9%) (100%) (23.5%) 
Degree of siderosis 
* NS 0 1+ 2+ 3+ 4+ Total 
Myocardium 0 2 8 3 5 0 0 36 
(77.8%) (8.3%) (13.9%) (0.0%) (0.0%) 
Bone marrow 4 1 1 17 13 0 3 2 
(3.1%) (3.1%)(53.1%)(40.6%)(0.0%) 
Spleen 3 0 4 16 8 5 33 
(0.0%) (12.1%) (48.5%) (24.2%) (15.2%) 
Pancreas 2 26 2 5 1 0 34 
(76.4%) (5.9%) (14.7%) (2.9%) (0.0%) 
• NS = No specimen 
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Table 5.8 
(iii) Iron deposition in systemic organs in patients 
with no hepatic iron accumulation. 
Myocardium Bone Marrow Spleen Pancreas 
No. of 
patients 
(+/total) 3/49 17/40 32/46 0/46 
percentage (6.1%) (42.5%) (70.0%) (0.0%) 
Degree of siderosis 
0 1+ 2+ 3+ 4+ TOTAL 
Myocardium 46 2 1 0 0 49 
(93.9%) (4.1%) (2.0%) (0.0%) (0.0%) 
Bone Marrow 23 4 6 6 1 40 
(57.5%) (10.%) (15.%) (15.%) (2.5%) 
Spleen 14 9 18 5 0 46 
(30.4%) (19.6%) (39.1%) (10.9%) (0.0%) 
Pancreas 0 0 0 0 0 0 
(0.0%) (0.0%) (0.0%) (0.0%) (0.0%) 
P value for correlation of hepatocytic iron with systemic 
tissue iron in all groups of patients 
Myocardium p < 0.001 
Bone Marrow p < 0.001 
Spleen no convergence 
Pancreas p < 0.001 
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SYSTEMIC TISSUES SIDEROSIS IN PATIENTS WITH SIGNIFICANT 
HEPATOCYTIC IRON DEPOSITION 
100% y-yp^  
11 
4+ 3+ 0 CON 4+ CON 3+ 
VARIOUS HEPATOCYTIC IRON GRADINGS 
X J MYOCARDIAL IRON W L PANCREATIC IRON 
F i g . 18 
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Table 5 • 9 Searle^ s histological grading of liver 
tissues in the autopsy group. 
Hepatocytes Iron Grading 
3+ 4+ TOTAL 
adolescence 0 o 1 3 
group 
(0.0%) (0.0%) 
adult 53 16 227 
group 
(23.3%) (7.0%) 
Kupffer cells Iron Grading 
3+ 4+ TOTAL 
adolescence 3 0 13 
group 
(23.1%) (0.0%) 
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This discussion will be presented in a similar manner as 
the results. It should be noted that we have 
concentrated on the subgroup termed significant 
hepatocytic siderosis• This is due to the association of 
disease and iron storage correlating best with the degree 
of iron deposition in hepatocytes. 
6.1 Correlation Between Histological Grading and 
Chemical Determination of Iron in the Liver Tissue 
Table 5.1.1 showed the percentage of error calculated 
from results of 2 commercial samples. These data reflect 
the accuracy of the assay. Deviation from the expected 
value was from -12.7% to 2.47%, and the estimated 
values of both levels were within the stated range. The 
coefficient of variation for the within batch precision 
was 8.3%, 4.1% and 5.8% respectively. Both accuracy and 
precision were acceptable. 
There was no significant difference between data 
from formalin fixed samples and paraffin embedded 
with paraffin removed tissues and it has been shown 
that paraffin removal has no effect on hepatic iron 
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concentration. The small standard deviation (土2.11 umol/g 
dry weight) from duplicate measurement of the liver 
tissues showed that the precision of the test is 
acceptable. 
By using the chemical determination of hepatic iron 
concentration as a reference, the histological method 
seems to be able to assess liver iron concentration 
satisfactorily. 
From the results, iron concentrations obtained chemically 
correlated well with histologic gradings of iron 
deposition in the liver ( p = 0.014 ) • 81.3% of 4 + 
iron grading in hepatocytes had an elevated iron 
concentration ( normal range used by Bassett (137) was 3-
33 umol/g dry weight and that used by Searle (144) was 5-
40 umol/g dry weight ) • Although only 18.1% of the 
patients with 3+ iron accumulation showed an increase in 
the iron concentration, a similar magnitude of patients 
also exhibited siderosis in systemic tissues in this 
group. Therefore it reflects that the significant level 
of 40 umol/g dry weight does identify a subgroup prone 
to systemic siderosis. It should be noted that the 
degree of systemic siderosis in myocardium and pancreas 
is low in these individuals. 
A grade of 3+ ( by Rowe‘ s method ) in our population 
where there is a mixed distribution of hepatic siderosis 
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may be over inclusive, but a subset is definitely prone 
to systemic siderosis. While the significance of 3+ 
siderosis in the majority is unknown, possibly if given 
enough time, it could develop into systemic siderosis. 
However, the opportunity for this to occur would be 
remote, since the majority of the individuals showing 
3+ siderosis are elderly and hepatocytes revealed 
“normal “ iron content chemically. 
The reason that some samples with significant hepatocytic 
siderosis fall below an arbitrary normal threshold of 
hepatic iron ( 40 umol/g dry weight ) as assessed by 
chemical method, may be due to the selection of tissue in 
histologic assessment. Only thin sections of the liver 
tissue are being studied in histologic grading of iron 
whereas a larger sample size is employed in chemical 
determination. If iron is not evenly distributed in the 
liver lobule, as in the presence of tumor or connective 
tissue (fibrosis, cirrhosis), it may cause discrepancy 
between the two methods. Hall et al. have recently used 
morphometry to assess this effect ( Hall et. al. 
unpublished abstract 1989 ). 
In our study, all samples with 3+ or 4+ iron gradings 
which did not correlate with chemical iron estimation had 
tumor or cirrhosis. This reflects one disadvantage of the 
histological method chosen, where the proportion of cells 
with iron deposition was not being considered, thus 
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resulting in the risk of overestimating hepatic iron 
content. Refinement of the histological iron estimation, 
where the intensity of iron load as well as the extent of 
cells involved should be taken into account in the future 
study. 
6.2 Iron Content of Neonates 
Total body iron stores at birth is very limited, only 
about 3 0 mg. In this study, we have shown that over 50% 
of the neonates from both surgical and post mortem group 
had significant hepatocytic siderosis. It is not 
surprising that children born with congenital hemolytic 
anemia accumulate iron. However, in this population, 
there remains a large proportion of neonates who appear 
to have significant iron storage with unknown etiology. 
Moreover, as shown from the results, the incidence of 
congenital hemolytic anemia among the significant 
hepatocytic siderosis group is at least 36%, which far 
exceeds the general incidence of all forms of congenital 
hemolytic anemias in this community (3) • In addition, as 
many of the cases were not tested for this disorder, the 
incidence of congenital hemolytic disease may be even 
higher. 
From these results, there appears to be a significant 
association between congenital hemolytic anemia and 
significant hepatocytic siderosis in our neonatal group 
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and therefore in our community. This is particularly 
important since the incidence for thalassemia is high 
in this region ( 68 ). 
The implications of these findings are that, the 
potential for iron storage disease in our community may 
begin at a very early stage of life, and by testing 
routinely in all neonatal and infant post mortem for 
hemolytic anemia, can resolve this question. 
6.3 Iron Content of the Children and Adolescene Group 
In the adolescence group, excessive iron deposition is 
much less significant. A high percentage of the 
population, 88.9% in the surgical group and 92.3% in the 
post mortem group had little iron deposition in the 
liver. Only 11.1% and 7.7% in both surgical and autopsy 
cases showed an increase in iron accumulation. 
The finding of such a small number of individuals with 
significant iron deposition in this group as compared to 
those in the neonatal group may be due to the inability 
of the neonates affected by significant hepatocytic 
siderosis to survive and the dilution effect of normal 
births. 
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6.4 Iron Content of the Adult Group 
The adult group is a selective group in a sense that all 
surgical cases are from biopsies or resections from 
patients who had suffered from hepatic associated 
diseases. On the other hand, although the post mortem 
group represents more of a general population, these 
cases are still selective, for they are not from a 
healthy group. In addition, during their course of 
disease, they may have received transfusions or other 
agents which are responsible for the hepatic iron 
overload. 
A high incidence of significant hepatocytic siderosis is 
seen in the adult population with 38.8% in the autopsy 
group and 30.8% in the surgical group which may be due 
to a combination of effects, e.g. transfusion and the 
high rate of liver disease in this region. 
When this result is compared to other studies on the 
prevalence of iron overload in other regions, there 
is significant discrepancy. However, incidence observed 
by other researchers were based on idiopathic 
hemochromatosis, whereas our study had included all forms 
of iron overload. (112, 113, 114, 115, 116) 
If we equate 3+ or 4+ iron grading in hepatocytes to a 
potential disease state, around 35% of the overall 
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population studied are "at risk", therefore the incidence 
of this potentially harmful degree of hemosiderosis in 
the population is high as assessed by Rowe‘s histological 
grading system. It will be discussed later that this 
result may be exaggerated as compared to result measured 
by other methods. However, there is evidence that a 
significant subgroup in this community is at risk, 
6.5 Relationship of Significant Iron Deposition with Sex 
Edwards had observed that the frequency of affected male 
was 10 times greater than that of female (149) . The 
present study showed that 33.8% of the male and 21.2% of 
the female in the surgical group and 39.0% of the male 
and 34.6% of the female in the post mortem group had 
significant iron storage. Although a higher percentage 
of male was found to be affected by this disorder, the 
extent was not as high as that reported by others, and 
statistical correlation between sex and hepatocytic iron 
deposition was not significant (p=0.1596). 
6.6 Association of Significant Iron Deposition with Age 
When severe iron overload is considered according to 
age, increasing number of patients with significant 
iron deposition were found in the older age groups. 
The mean age for significant hepatocytic siderosis was 63 
years for the autopsy group and 51 years for the surgical 
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patients. This suggests that iron accumulation in this 
population is a slow, life-long process, although due to 
the severity of iron storage, the index can present 
earlier in genetic hemochromatosis. This is consistent 
with other studies ( 141, 150 ). 
The proportion of patients with significant hepatocytic 
siderosis in each decade in the post mortem group shows 
steady exponential pattern rising continuously into the 
8th decade, reinforcing the notion that iron storage in 
the population is a slow and steady process. 
In contrast, the proportion of SHS in the adults of the 
surgical group reaches a peak in the 6th decade and drops 
slowly thereafter. This may be a reflection of (i) a 
more severe disease and/or (ii) that the hepatic disease 
which they have is related to the significant hepatocytic 
siderosis and is manifested earlier. 
6.7 Mode of Iron Distribution in the Liver 
If we consider patients with significant hepatocytic 
siderosis, most of these patients also have a high grade 
of iron deposited in the Kupffer cells, 78 ( 32.5% ) in 
the post mortem group and 115 ( 26.0% ) in the surgical 
group. This indicates that a mixed pattern of iron 
deposition predominates to a large degree. 
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Increased amount of iron derived from oral ingestion 
deposits mainly in hepatocytes and that parenteral iron 
overload characteristically accumulates in the RE system 
( 1 5 0 ) • Also with recent suggestion that there may be 
some redistribution of iron from Kupffer cells to 
hepatocytes ( 151 ), this mixed pattern may, therefore, 
occur in patients who have been exposed to parenteral 
iron with or without increased absorption. A possible 
factor in our population such as congenital hemolytic 
disease could account for such a mixed pattern. 
In chronic hemolysis, senescent red cells are being 
phagocytosed in the RE system ( including Kupffer cells ) 
thus releasing iron, and concurrently, there is increased 
iron absorption due to the expanding erythropoiesis, 
which may be significantly greater than that in genetic 
hemochromatosis ( 17, 152, 153, )• The absorbed iron 
would preferentially distribute to hepatocytes. 
The difference in incidence between the post mortem group 
and surgical group with respect to the mixed pattern in 
significant hepatocytic siderosis, could be explained by 
the increased likelihood that post mortem patients would 
have received blood transfusions. However, in examining 
clinical notes of 40 patients in the group, only 12 ( 
30% ) had a recorded history of blood transfusion. Most 
of these transfusions were within 2 weeks prior to death. 
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Based on these data, one cannot easily ascribe blood 
transfusion as a significant cause of the mixed pattern. 
Patients might have received transfusions elsewhere, 
however, there was no indication of that and it seemed 
remote that it should be a major factor affecting such a 
large number of patients. 
In addition, 11 ( 4.6% ) patients in the post mortem 
group and 16 ( 3.6% ) patients in the surgical group 
showed severe iron deposition predominantly in the 
hepatic parenchymal cells. These patients are suspected 
to have acquired iron via absorption i.e. genetic 
hemochromatosis or increased iron absorption for another 
reason, e.g. increased ingestion of iron, alcohol or 
chronic low grade hemolysis. 
6.8 Association with Fibrosis 
Whether the magnitude of fibrosis is directly 
proportional to the severity of iron deposition in any 
case is controversial. Some researchers ( 154, 155 ) 
suggested that the extent of fibrosis affected by 
different amount of iron varies. 
To consider the role of hepatocytic siderosis in the 
development of hepatic fibrosis/cirrhosis, we correlated 
the degree of fibrosis with the degree of hepatocytic 
iron deposition. Statiscally we found no direct 
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relationship (p=0.378), although some patients with 
significant hepatocytic siderosis had a more severe 
degree of fibrosis. 
Hong Kong is an area in which chronic hepatitis B is very 
common. Since it can cause hepatic fibrosis/cirrhosis, 
its prevalence will clearly influence the above 
correlation. In addition, it is not known even if loose 
correlation of significant hepatocytic siderosis is a 
cause or an effect. 
6.9 Relationship with Systemic Tissues 
The most severe form of significant hepatocytic siderosis 
is a 4+ iron accumulation in the hepatocytes. If indeed 
SHS can predispose to other disease, it should be 
revealed in the group of patients who have 3+ and 
particularly 4+ iron deposition in the hepatocytes. 
Therefore, we chose to do a follow up study in this group 
of individuals. This included an assessment of systemic 
siderosis in the post mortem group and some clinical 
features in the surgical group. 
The present study shows that over 60% of the individuals 
with 4+ and 20% with 3+ iron stored in hepatocytes 
exhibited iron deposition in systemic tissues, such as 
myocardium and pancreas. Iron is known to be predisposed 
to these organs and where it may cause related diseases, 
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e.g. diabetes mellitus, and cardiomyopathy. (143, 156, 
157, 158) 
Although the degree of iron deposition in these organs ( 
pancreas and myocardium ) is low in most cases, as 
assessed by Rowe's method, it does support the concept 
that significant hepatocytic siderosis in our population 
has the potential of causing significant disease. 
In fact, in a clinical follow up of 21 surgical cases 
with 4+ hepatic siderosis, the incidence of previously 
diagnosed diabetes mellitus was 23.8% , thalassemia 
was 19%, hepatocellular carcinoma was 47.6%. All were 
significantly higher* than what would be expected in the 
general population (6) • When the incidence of these 
disorders were compared with the normal population, 
diabetes mellitus was found to be 125 times more frequent 
(6) , thalassemia was 5 times more frequent (3) and 
hepatocellular carcinoma was 251 times more frequent (6)• 
This suggests a close relationship between significant 
hepatocytic siderosis and these diseases. This is 
consistent with Milder's (83) and Niederau's (159) 
findings. Milder has found that 17.6% of his patients 
with hemochromatosis developed hepatoma and Niederau has 
found that 30.1% of his index cases died of liver cancer 
and 18.9% died of diabetes. 
Although diabetes mellitus itself may cause liver disease 
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without implicating iron storage, diabetes mellitus 
associated liver disease is unusual. Besides, this 
disorder has some characteristic histologic features, 
which are not present in our group. Therefore, it 
is believed that there is a causal relationship between 
iron storage and diabetes mellitus within this group, 
although there is also the possibility that liver 
disease per se is associated with diabetes mellitus. 
Moreover, there is a close correlation of the magnitude 
of patients showing systemic siderosis in the test group 
and the control group, especially in subjects with 4+ 
hepatocytic iron deposition. This would further support 
that results obtained from the test group are 
reflections of the community. 
6.10 The Control Group 
Our control group, comprised of subjects who were 
previously well, but died from trauma within 48 hours. 
By the selection criteria, this would most probably 
reflect a non-hospital based group, i.e. normal controls. 
In this group of "healthy" individuals, the distribution 
of age and sex is comparable to our test group. Severe 
hemosiderosis is found and the pattern of deposition of 
iron also resembles that of the test population. 
Since the incidence of significant hepatocytic siderosis 
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and pattern of distribution of iron exhibit a similar 
order of magnitude among the surgical, post mortem and 
control group. There is good evidence that these 
findings are a true reflection of the community, 
A larger control group would be preferrable, however, 
given the stringent criteria for inclusion in this group, 
it was not possible in this study. 
6.11 A Second Histological Method in Grading Iron 
Deposition in Liver 
Searle,s method is a modification of Rowe‘s procedure. 
The major difference between the two methods is the 
criteria set for the cut off point for a 3+ or 
significant iron grading, where Searle is more stringent. 
An attempt was made by using this modification to 
reassess post mortem specimens with significant 
hepatocytic siderosis ( as graded by Rowe‘s method ) to 
observe its effect on the incidence of significant 
hepatocytic siderosis under a more stringent guideline. 
Although results by S e a r l e m e t h o d showed a decrease in 
the number of patients with 3+ iron grading in 
hepatocytes, as compared to results obtaineci by Rowe‘ s 
procedure ( from 72 to 53 ), the incidence of significant 
hepatocytic siderosis remains high ( 30.3% ) in the adult 
group. 
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since there was only 1 individual found to have 3+ iron 
accumulation in hepatocytes by Rowe's method in the 
adolescent group, the change was not significant. 
When we compared these results with iron concentration 
determined by chemical method, it showed similar results 
as those obtained by Rowe‘s procedure. Patients found to 
have an iron concentration above 40 umol/g dry weight, 
remain the same ( 81.3% ) in the group with 4+ iron 
grading in hepatocytes. Although there is a slight 
increase ( from 18.2% to 20.0% ) in individuals with an 
elevated iron concentration in the group of subjects with 
3+ iron grading in hepatocyte, the increase is only 
minor. All these further support the high incidence of 
significant hepatocytic siderosis in the studied group as 
assessed histologically. However, it also indicates the 
possible shortcoming of histological grading systems in 
giving an accurate indication of disease potential. 
6.12 Siderosis in the Hong kong Population 
This study suggests a high incidence of significant 
hepatocytic siderosis prevailing in the Hong Kong 
population. Some of the factors contributing to this 
effect may be due to the following: 
(i) Chronic hemolysis ( common in Hong Kong )• 
(ii) Chronic liver disease, e.g. portosystemic shunts. 
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(iii) High consumption of alcohol by local people, 
although signifcance in this factor is unknown. 
(iv) Kaschin-Beck disease — a disease which is limited to 
northern Chinese, however, its full blown form has not 
been recognised in Hong Kong. The possibility of a 
forme—fruste should be theoretically considered (see 
page 25). 
(V) Local effect of hepatocellular carcinoma (high 
incidence in Hong Kong (6) and there is a marked 
association of significant hepatocytic siderosis and 
hepatocellular carcinoma in our group - up to 4 7 % . ) 
All of the above may enhance body iron stores and may 
lead to associated diseases, such as diabetes mellitus, 
myocardial dysfunction, arthropathy, liver disease, 
hepatocellular carcinoma and all these are common in 
Hong Kong. Moreover, both diabetes mellitus and 
hepatocellular carcinoma are more common in a subset of 
our significant hepatocytic siderosis group than in the 
general age related population. 
This study has demonstrated an apparent association 
between severe hepatocytic siderosis and hepatocellular 
carcinoma in the Hong Kong population, for many of the 
biopsy cases with 4+ siderosis in hepatocytes ( 47% ) had 
this malignancy. The logical assumption would be that, 
hemosiderosis along with chronic hepatitis B have 
predisposed to the development of hepatocellular 
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carcinoma. However, the possibility that hepatocellular 
carcinoma causes ( adjacent ) hemosiderosis is a 
theoretical consideration. 
Due to the high incidence of thalassemia in this area (3), 
it inay result in heinosideirosis and. heinochroinatosis • In 
addition, neonatal thalassemia may manifest clinically 




On review, we can conclude that the study reflects a 
high incidence of significant hepatocytic siderosis 
prevailing in this community. It occurs predominantly in 
males and at a mean age of 55 years. Over 30% of the 
patients with significant hepatocytic siderosis in the 
studied group revealed siderosis in systemic organs, 
suggesting a possible close association between 
significant hepatocytic siderosis and diseases related 
with the tissue siderosis. Indeed, diabetes mellitus and 
hepatocellular carcinoma appear to be higher in this 
group. 
The mixed pattern of iron deposition found in patients in 
this study, where iron is distributed both in hepatocytes 
and Kupffer cells is suggestive of increased iron 
absorption in combination with “ parenteral “ iron 
administration or release, in part secondary to 
ineffective erythropoiesis. It may be due to the high 
prevalence of thalassemia in this region, as this, of all 
the possible factors considered, is likely to result in 
such a mixed pattern and would be consistent with the 
apparent slow build—up of hepatic iron, reaching 
ascendency in the 7th or 8th decade. 
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This factor may also explain the neonatal siderosis and 
this is being further investigated by studying a similar 
Australian group where the findings may cast light on 
the entity "Neonatal Hemochromatosis". 
This is a retrospective study, therefore it is not ideal. 
In many cases, we are unable to obtain necessary 
information pertaining to the study from the clinical 
notes of the patients. It is almost impossible to have 
additional tests or further workup on these individuals, 
even in the surgical group because many are deceased. 
Furthermore, as in all methodologies, there are 
limitations in both histological and chemical procedures. 
The matrix of the tissues, distribution of iron, and 
staining technique may all affect the histological 
interpretation of the iron gradings. As for atomic 
absorption spectrophotometry, its reliability is best 
represented in samples with low iron concentration, 
therefore specimens with high iron content would be 
subjected to dilution error. The correlation between 
chemical determination and histological iron gradings 
( b y both Rowe's and Searle's methods ) is unsatisfactory 
in patients with 3+ iron accumulation in hepatocytes. 
Further work should be required to investigate if 
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